Rate My Professor David Leavesley

David Leavesley's research centers on the cellular basis of disease, particularly epithelial wound repair and healing, with specializations in wound healing, tissue engineering, cell culture and proliferation, cell signaling, cancer biology, biomaterials, immunohistochemistry, flow cytometry, primary cell culture, and cellular biology. Key interests include stalled inflammation in non-healing wounds potentially due to extracellular traps, scar remediation using traditional Chinese medicine compounds like shikonin, diagnostic and prognostic biomarkers from wound fluids, microRNAs and long non-coding RNAs in healing, and development of ex vivo human skin equivalent models for therapy testing and toxicology. Select publications include 'A sustainable strategy for generating highly stable human skin equivalents based on fish collagen' (2024), 'Hydrogel dressings with intrinsic antibiofilm and antioxidative dual functionalities accelerate infected diabetic wound healing' (2024), 'Automated electrical stimulation therapy accelerates re-epithelialization in a 3D in vitro human skin wound model' (2023), 'Vascular and Collagen Target: A Rational Approach to Hypertrophic Scar Management' (2021), 'Keratin-Alginate Sponges Support Healing of Partial-Thickness Burns' (2021), and 'Vitronectin—master controller or micromanager?' (2013). He contributes as an editorial board member for Biology (MDPI) and Frontiers in Molecular Biosciences, fostering advancements in biomedical sciences.